DISC MEDICINE INC
IRONNASDAQπ #1620 by market capUS Equity
$82.82βΌ $0.35 (β0.42%)
After hours Β· at closeTrack IRON
Get earnings, price moves & breaking news on Telegram
24hβΌ 0.4%
7dβ² 10.3%
14dβ² 46.3%
30dβ² 25.6%
ytdβ² 4.3%
1yβΌ 2.7%
π¦Market Cap
$3.67B
Small Cap
πRevenue Growth (YoY)
β
πGross Margin
β
π΅FCF Margin
β
βοΈP/S Ratio
β
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $82.28 β $84.87
- 52-Week Range
- $40.00 β $99.50
- Volume (shares)
- 42,133
- Avg Volume (shares)
- β
- Shares Outstanding
- 44.4M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- β
- P/E Ratio
- β
- P/S Ratio
- β
- EPS (TTM)
- $-6.57
- Dividend Yield
- β
- Dilution (1yr)
- +17.9%
DISC MEDICINE INC
IRONFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0β² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$236Mβ² +81.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$181Mβ² +92.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
35.3Mβ² +17.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$89MβΌ β$73M YoY
About DISC MEDICINE INC
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
β‘Momentumβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst data unavailable.
Latest News & Updates
News unavailable.